HLHS Cause to Cure

Hypoplastic Left Heart Syndrome Program from Mayo Clinic

Share this:
August 12, 2015

Mayo Clinic’s Transplant Programs Rank High for Survival Rates

By suzannerferguson

Mayo Clinic’s transplant programs were recently recognized as the largest provider of transplants in the United States. A national database of transplant statistics, the Scientific Registry of Transplant Recipients (SRTR), ranked Mayo Clinic’s transplant programs in Arizona, Florida and Rochester statistically better than expected in terms of patient and graft survivals at the repoorrted time points of one month, one year and three years. In 2014 alone, there were 1,132 solid organ transplants performed.

Being ranked "statistically better than expected" is considered to be significant for transplant programs, according to David Douglas, M.D., Transplant Hepatology, director of the Transplant Program on Mayo Clinic’s Arizona campus.

Only a small number of transplant centers earn the ranking and Mayo has received the ranking across all three of its campuses.

Read the entire article on the Mayo Clinic News Network.


The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) is a collaborative network of specialists bonded by the vision of delaying or preventing heart failure for individuals affected by congenital heart defects including HLHS. The specialized team is addressing the various aspects of these defects by using research and clinical strategies ranging from basic science to diagnostic imaging to regenerative therapies.

Tags: CHD, HLHS, Hypoplastic Left Heart Syndrome, Mayo Clinic, transplant, Uncategorized

Please login or register to post a reply.
Contact Us · Privacy Policy